From: Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study
Number | Percent | |||
---|---|---|---|---|
Respondent had heard of misoprostol | 79 | 72 | ||
Knowledge of conditions | Used for | Registered for | ||
N | % | N | % | |
Duodenal or gastric ulcer | 59 | 75 | 48 | 61 |
Prophylaxis of NSAID-induced peptic ulcers | 5 | 6 | 4 | 5 |
Prevention of PPH | 1 | 1 | 1 | 1 |
Treatment of PPH | 3 | 4 | 2 | 3 |
PAC | 10 | 13 | 10 | 13 |
Treatment for intrauterine fetal death (IUFD) | 1 | 1 | 0 | 0 |
Cervical ripening | 2 | 3 | 1 | 1 |
Termination of pregnancy | 30 | 38 | 5 | 6 |
Knowledge of storage instructions | N | % | ||
Store away from heat | 66 | 84 | ||
Store away from moisture | 22 | 28 | ||
Knowledge of side effects | ||||
Could not name any side effects | 37 | 47 | ||
Diarrhoea | 6 | 8 | ||
Nausea | 4 | 5 | ||
Fever/chills | 3 | 4 | ||
Weakness | 5 | 6 | ||
Bleeding | 6 | 8 | ||
Headaches | 3 | 4 | ||
Dizziness | 11 | 14 | ||
Abortion | 10 | 13 |